F067 Pediatric Dermatology M&M
DESCRIPTION
Morbidity and mortality sessions provide caregivers with a structured forum to review adverse outcomes in medicine. Our session will be a case-based review of complications encountered while caring for children in both inpatient and outpatient settings. We will review cases that provide teaching points to improve care by decreasing errors in communication and practice. Cases will also solidify the difference between adverse events that can be avoided and those that are inherent risks of illness. This forum is a blameless environment to help all of us learn.
LEARNING OBJECTIVES
Identify gaps in communication that lead to error.
Differentiate adverse events that are risks of therapy or disease and those that result from error.
Discuss strategies for handling and coping with adverse events.
SCHEDULE
3:30 PM
Pediatric Dermatology M&M
DIRECTOR
Nicole Noelani Harter, MD, FAAD
SPEAKERS
Megan Craddock, MD, FAAD
Meagan Elizabeth Hughes, MD, FAAD
Kalyani Marathe, MD, MPH, FAAD
Mollie Oudenhoven, MD, FAAD
DISCLOSURES
Megan Craddock, MD, FAAD
No financial relationships exist with ineligible companies.
Nicole Noelani Harter, MD, FAAD
Regeneron – Speaker/Faculty Education(Honoraria); Sanofi – Speaker/Faculty Education(Honoraria);
Meagan Elizabeth Hughes, MD, FAAD
No financial relationships exist with ineligible companies.
Kalyani Marathe, MD, MPH, FAAD
Guidepoint Global, LLC – Advisory Board(Fees); Leo Pharma – Advisory Board(Honoraria);
Mollie Oudenhoven, MD, FAAD
No financial relationships exist with ineligible companies.